Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Glucocorticoid-Induced Osteoporosis in Patients With Rheumatic Diseases. The STOP-Study: a Randomized Placebo Controlled Trial With Alendronate Versus Alfacalcidol.

NCT00138983 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.

NCT NCT00138983
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00138983 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Glucocorticoid-Induced Osteoporosis in Patients With Rheumatic Diseases. The STOP-Study: a Randomized Placebo Controlled Trial With Alendronate Versus Alfacalcidol.
Lead sponsor
UMC Utrecht
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2000
Completion date
November 30, 2003
Enrollment
200
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

giant cell arteritis, polymyalgia rheumatica, polymyositis, rheumatoid arthritis, wegener's granulomatosis